Panakes Fund I

Panakes Fund I is an early-stage venture capital fund managed by Panakes Partners, an Italy-based firm founded in 2015. The fund focuses on investing in the life sciences and healthcare sectors across Europe and Israel, with particular emphasis on medical devices, diagnostics, and healthcare technology systems. Investments typically range from EUR 5 million to EUR 6 million. Leveraging a broad network of business contacts and extensive domain expertise, Panakes Partners aims to provide proactive portfolio management and foster relationships with selected industrial partners to support the growth of its portfolio companies.

Andrea Ballerini

Associate

Alessio Beverina

Co-Founder & Managing Partner

Laura Brolis

Chief Financial Officer

Barbara Castellano

Partner

Lorenzo Giordano

CFO

Fabrizio Landi

Co-Founder & Managing Partner

Giacomo Piccinini

Associate

Alessio Piuma

Investment Manager

Diana Saraceni

Co-Founder & Managing Partner

Marco Sardina

Scientific Partner

Robbie Woodman

Partner

Past deals in Ireland

Vivasure Medical

Series D in 2022
Vivasure Medical Limited is a medical device company based in Galway, Ireland, focused on the research, development, and manufacturing of arterial and venous closure devices utilizing its proprietary PerQseal technology. The company specializes in creating polymer implants and delivery systems aimed at facilitating minimally invasive vessel closures in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, specifically designed to close large arteriotomies during transcatheter procedures like transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical aims to enhance patient outcomes in vascular access procedures through innovative medical solutions.

Vivasure Medical

Series C in 2016
Vivasure Medical Limited is a medical device company based in Galway, Ireland, focused on the research, development, and manufacturing of arterial and venous closure devices utilizing its proprietary PerQseal technology. The company specializes in creating polymer implants and delivery systems aimed at facilitating minimally invasive vessel closures in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, specifically designed to close large arteriotomies during transcatheter procedures like transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical aims to enhance patient outcomes in vascular access procedures through innovative medical solutions.